SLC1A2 and depressive disorder: Animal models of depression, including those using CMS, chronic unpredictable stress (CUS), corticosteroid exposure, or congenital helplessness, replicate these changes, showing reduced mRNA and protein levels of GLT-1 and GLAST across key brain regions.